Related Experiment Video

Updated: May 16, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

What is the impact, present and future, of novel targeted agents in acute lymphoblastic leukemia?

Dan Douer1

  • 1Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, 1275 York Ave, New York, NY 10065, USA. douer@mskcc.org

Best Practice & Research. Clinical Haematology
|December 4, 2012
PubMed

Insights

New targeted agents offer hope for acute lymphoblastic leukemia (ALL) in adults. Current treatments are inadequate, necessitating novel therapeutic strategies to improve patient outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Adult acute lymphoblastic leukemia (ALL) lacks a definitive standard of care.
  • Existing treatment regimens for adult ALL yield suboptimal outcomes.
  • There has been a stagnation in treatment progress for adult ALL over recent decades.

Purpose of the Study:

  • To review emerging therapeutic strategies for adult acute lymphoblastic leukemia (ALL).
  • To discuss the potential impact of novel targeted agents in ALL treatment.
  • To evaluate the combination of targeted agents with chemotherapy.

Main Methods:

  • Literature review of recent advancements in ALL treatment.
  • Analysis of studies involving novel targeted agents.
  • Discussion of combination therapy approaches.

Main Results:

  • Novel targeted agents show promise as monotherapy and in combination regimens.
  • These new strategies aim to overcome the limitations of current ALL treatments.
  • Early data suggests potential for improved overall outcomes in adult ALL.

Conclusions:

  • There is a critical need for innovative treatment approaches in adult ALL.
  • Targeted therapies represent a promising avenue for improving ALL patient outcomes.
  • Further research and clinical trials are essential to validate these new strategies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...